Phase II study of tauromustine in malignant glioma.
Gregor A, Rampling R, Aapro M, Malmström P, Whittle IR, Rye R, Stewart M, Sellar R, Demierre B, Ironside JW, et al.
Gregor A, et al. Among authors: ironside jw.
Eur J Cancer. 1992;28A(12):1959-62. doi: 10.1016/0959-8049(92)90236-u.
Eur J Cancer. 1992.
PMID: 1419289
Clinical Trial.